Major Growth Driver Identified in 2025 Platelet Aggregation Devices Market: The Increasing Incidence Of Target Diseases Is Driving The Platelet Aggregation Devices Market

Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts.

Platelet Aggregation Devices Market Size Valuation Forecast: What Will the Market Be Worth by 2025?
The market size for platelet aggregation appliances has seen exponential growth in the recent years. The industry, valued at $0.83 billion in 2024, is anticipated to escalate to $1.04 billion by 2025, showcasing a compound annual growth rate (CAGR) of 24.9%. The reason behind such substantial historic growth includes a number of factors such as the increasing incidence of cardiovascular disease, a rise in bleeding disorders, heightened awareness concerning health diagnostics, an uptick in the count of surgical procedures, and better diagnostic precision.

Platelet Aggregation Devices Market Size Forecast: What's the Projected Valuation by 2029?
In the coming years, it is predicted that the market size for platelet aggregation devices will experience a significant increase. The market is projected to expand to $2.46 billion by 2029, with a compound annual growth rate (CAGR) of 23.9%. This surge during the forecast period can be associated with an escalating aging populace, an increased demand for point-of-care testing, the development of personalized medicine, support and approvals from regulators, and a growing frequency of chronic illnesses. Key market trends for the forecasted period consist of the introduction of artificial intelligence into diagnostics, the creation of portable platelet aggregation instruments, enhanced cooperation between biotech companies and healthcare providers, the rising relevance of data analytics in healthcare and a shift towards home-based diagnostic procedures.

View the full report here:
https://www.thebusinessresearchcompany.com/report/platelet-aggregation-devices-global-market-report

What Are the Drivers Transforming the Platelet Aggregation Devices Market?
The escalation in occurrences of particular diseases is projected to fuel the growth of the platelet aggregation devices market. When referring to target diseases, these are specific health conditions that demand significant attention in terms of prevention, diagnosis and treatment, due to their substantial influence on public health- these include conditions such as cancer, cardiovascular diseases and diabetes. Platelet aggregation devices serve to lessen the occurrence of these target diseases by facilitating early identification and effective handling of blood clotting risks, hence averting health complications such as heart attacks and strokes amongst susceptible individuals. An instance worth noting is the global health statistics published by the International Agency for Research on Cancer (IARC), a France-based cancer-specialized agency under the World Health Organization (WHO), in February 2024. According to this, there were approximately 20 million new cancer cases and 9.7 million deaths in 2022. The projections predict a 77% surge to more than 35 million new cases by 2050. Lung cancer topped the list globally with 2.5 million fresh cases (12.4%), closely followed by breast cancer in women (2.3 million cases, 11.6%), colorectal cancer (1.9 million cases, 9.6%), prostate cancer (1.5 million, 7.3%), and stomach cancer (970,000, 4.9%). Thus, the rising prevalence of these target diseases is propelling the growth of the platelet aggregation devices market.

Get your free sample here:
https://www.thebusinessresearchcompany.com/sample.aspx?id=15896&type=smp

What Long-Term Trends Will Define the Future of the Platelet Aggregation Devices Market?
Leading businesses in the platelet aggregation devices market are shifting emphasis towards generating innovative solutions, exemplified by the introduction of advanced products like the pioneering platelet pooling set. This breakthrough is projected to buttress the U.S. platelet supply and accommodate escalating needs. A platelet pooling set employed in plateletpheresis processes amalgamates and concentrates platelets from an array of donors into a singular unit ready for transfusion therapy. For instance, during February 2023, TERUMO BCT INC., an American firm that specializes in blood components and cell technology, declared the sanction for the IMUGARD WB Platelet Pooling Set granted by the FDA, the American federal agency. This allows for prolonged platelet shelf life, FDA-approved storage for up to seven days, and the procurement of platelets from whole blood donations, which will boost flexibility and availability in the platelet aggregation devices market. This product launch symbolizes a noteworthy technological progression, filling the gaps in platelet availability, optimizing supply management, and reinforcing the overburdened U.S. platelet supply to fulfil the surging demand in crucial medical procedures such as chemotherapy and organ transplants.

Which Segments in the Platelet Aggregation Devices Market Offer the Most Profit Potential?
The platelet aggregation devices market covered in this report is segmented -

1) By Product: Reagents, Systems, Consumables And Accessories
2) By Type: Four Channel, Dual Channel, Eight Channel
3) By Technology: Optical, Impedance, Other Technologies
4) By Application: Clinical Applications, Research Applications, Cardiovascular Applications, Orthopedic Applications, Other Applications
5) By End-User: Standalone Hospitals, Diagnostic Laboratories, Research And Academic Institutes, Other End Users

Subsegments:
1) By Reagents: Platelet Aggregation Assay Reagents, Coagulation And Anticoagulation Reagents
2) By Systems: Platelet Aggregation Testing Systems, Automated Platelet Aggregation Systems
3) By Consumables And Accessories: Sample Collection Kits, Testing Plates And Cuvettes, Calibration Kits

Tailor your insights and customize the full report here:
https://www.thebusinessresearchcompany.com/customise?id=15896&type=smp

Which Firms Dominate the Platelet Aggregation Devices Market by Market Share and Revenue in 2025?
Major companies operating in the platelet aggregation devices market are Roche Holding AG, Cytiva (Danaher Corp.), Siemens Healthineers, Sysmex Corporation, WerfenLife S.A., Haemonetics Corporation, Helena Laboratories Corporation, Sarstedt AG & Co. KG, Sekisui Diagnostics LLC, Diagnostica Stago, Accriva Diagnostics Holdings Inc., Drucker Diagnostics, Sentinel CH. SpA, ADInstruments, Chrono-Log Corporation, Bio/Data Corporation, Haemochrom Diagnostica GmbH, AggreDyne Inc., Hart Biologicals Ltd., Stago

Which Regions Offer the Highest Growth Potential in the Platelet Aggregation Devices Market?
North America was the largest region in the platelet aggregation devices market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the platelet aggregation devices market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Purchase the full report today:
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=15896

This Report Supports:
1.Business Leaders & Investors - To identify growth opportunities, assess risks, and guide strategic decisions.
2.Manufacturers & Suppliers - To understand market trends, customer demand, and competitive positioning.
3.Policy Makers & Regulators - To track industry developments and align regulatory frameworks.
4.Consultants & Analysts - To support market entry, expansion strategies, and client advisory work.

Connect with us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company,
Twitter: https://twitter.com/tbrc_info,
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ.

Contact Us
Saumya Sahey
Europe: +44 7882 955267,
Asia: +44 7882 955267 & +91 8897263534,
Americas: +1 310-496-7795
Email: saumyas@tbrc.info

Learn More About The Business Research Company
With over 15,000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Our flagship product, the Global Market Model delivers comprehensive and updated forecasts to support informed decision-making.

This release was published on openPR.